Chase Investment Counsel Corp Innoviva, Inc. Transaction History
Chase Investment Counsel Corp
- $262 Million
- Q1 2024
A detailed history of Chase Investment Counsel Corp transactions in Innoviva, Inc. stock. As of the latest transaction made, Chase Investment Counsel Corp holds 74,000 shares of INVA stock, worth $1.21 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
74,000
Previous 68,000
8.82%
Holding current value
$1.21 Million
Previous $1.09 Million
3.39%
% of portfolio
0.43%
Previous 0.48%
Shares
4 transactions
Others Institutions Holding INVA
# of Institutions
220Shares Held
78.8MCall Options Held
45.9KPut Options Held
14.1K-
Black Rock Inc. New York, NY10.1MShares$166 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$119 Million19.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.29MShares$103 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.27MShares$103 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$103 Million0.14% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.14B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...